Extended‐spectrum β‐lactamase (ESBL)‐producing organisms are emerging as a cause of
infection in outpatients in many areas of the world. Most of these involve urinary tract …

Study Objective. To determine epidemiologic factors of extended‐spectrum β‐lactamase
(ESBL)‐producing Escherichia coli or Klebsiella pneumoniae in a nonoutbreak setting …

Extended-spectrum β-lactamases (ESBLs), which hydrolyse extended-spectrum
cephalosporins and are inhibited by clavulanic acid, are spreading among …

During the last decade, community-acquired extended-spectrum beta-lactamase (ESBL)-
producing bacteria, and in particular Escherichia coli producing ESBLs of the CTX-M-type …

Extended-spectrum b-lactamases (ESBLs) form a heterogeneous group that share the
property of hydrolytic activity against the oxyimino-b-lactams while remaining susceptible to …

Background Community-associated infections caused by extended-spectrum beta-
lactamase (ESBL) producing bacteria are a growing concern. Methods Retrospective cohort …

The spread of extended-spectrum β-lactamases (ESBLs) in nosocomial and community-
acquired enterobacteria is an important challenge for clinicians as the therapeutic options …

Nosocomial infections caused by extended-spectrum β-lactamase (ESBL)—producing gram-
negative bacteria complicate therapy and limit treatment options. However, the clinical …

Objectives: Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli have been
increasingly recognized in the community. The aim of this study was to determine the …

Although the first reports on extended‐spectrum β‐lactamase (ESBL)‐producing isolates in
long‐term‐care facilities (LTCFs) appeared 10 years ago, there are still scanty data on this …